Talis Biomedical Corporation (TLIS)

Market Cap	3.10M
Revenue (ttm)	408.00K
Net Income (ttm)	-51.03M
Shares Out	1.82M
EPS (ttm)	-28.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	1.700
Previous Close	1.700
Day's Range	1.700 - 1.700
52-Week Range	1.370 - 9.600
Beta	1.57
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 21, 2025

About Talis Biomedical

Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2013
• Employees: 99
• Stock Exchange: OTCMKTS
• Ticker Symbol: TLIS

Financial Performance

In 2023, Talis Biomedical's revenue was $2.13 million, a decrease of -55.65% compared to the previous year's $4.81 million. Losses were -$62.01 million, -45.13% less than in 2022.